OLoughlin v. AESA Enterprises

2026 UT App 41
CourtCourt of Appeals of Utah
DecidedMarch 19, 2026
DocketCase No. 20231088-CA
StatusPublished

This text of 2026 UT App 41 (OLoughlin v. AESA Enterprises) is published on Counsel Stack Legal Research, covering Court of Appeals of Utah primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
OLoughlin v. AESA Enterprises, 2026 UT App 41 (Utah Ct. App. 2026).

Opinion

2026 UT App 41

THE UTAH COURT OF APPEALS

MARTIN O’LOUGHLIN, Appellant, v. ASEA, LLC; REOXCYN MEDICAL RESEARCH, INC.; REOXCYN DISCOVERIES GROUP, INC.; REOXCYN INNOVATION GROUP, LLC; MICHAEL SORENSEN; AND ASEA ENTERPRISES, LLC, Appellees.

Opinion No. 20231088-CA Filed March 19, 2026

Fourth District Court, Provo Department The Honorable Derek P. Pullan No. 190400761

Troy L. Booher and Caroline A. Olsen, Attorneys for Appellant

H. Scott Jacobson, Graden P. Jackson, and Axel Trumbo, Attorneys for Appellees Reoxcyn Medical Research, Inc.; Reoxcyn Discoveries Group, Inc.; Reoxcyn Innovation Group, LLC; and Michael Sorensen

Cameron M. Hancock, Justin W. Starr, Michael A. Eixenberger, and Christopher A. Bates, Attorneys for Appellees ASEA Enterprises, LLC and ASEA, LLC

JUDGE GREGORY K. ORME authored this Opinion, in which JUDGES MICHELE M. CHRISTIANSEN FORSTER and RYAN D. TENNEY concurred.

ORME, Judge: O’Loughlin v. ASEA Enterprises

¶1 Martin O’Loughlin was an early investor in ASEA, 1 a pharmaceutical supplement company. ASEA’s founders, Michael Sorensen among them, assured O’Loughlin that the company owned the intellectual property behind its products. But after O’Loughlin learned that this was not the case, he sued ASEA, Sorensen, and the company that actually owned the intellectual property—Reoxcyn. 2 Before trial, ASEA filed a motion in limine to exclude O’Loughlin’s evidence of damages due to his failure to initially disclose the methodology for calculating them. The district court granted the motion in limine and, concluding that the motion was dispositive, dismissed the case.

¶2 On appeal, O’Loughlin challenges these rulings by the district court and its award of attorney fees. We affirm the court’s grant of the motion in limine and dismissal of the case. We also affirm the court’s attorney fees award to ASEA and its decision to award fees to Sorensen, but we vacate Reoxcyn’s award. And because the attorney fees were not originally allocated as between Sorensen and Reoxcyn, we remand for the district court to determine the amount due to Sorensen individually.

BACKGROUND 3

¶3 In 2008, Sorensen and his fellow founders courted O’Loughlin’s investment in ASEA, representing that the new company would develop pharmaceutical supplements.

1. We refer to the ASEA entities collectively.

2. We also refer to the Reoxcyn entities collectively.

3. In reviewing what is effectively the district court’s grant of summary judgment, we recite the facts “in the light most favorable to the nonmoving party.” Ockey v. Club Jam, 2014 UT App 126, ¶ 2 n.2, 328 P.3d 880 (quotation simplified).

20231088-CA 2 2026 UT App 41 O’Loughlin v. ASEA Enterprises

O’Loughlin eventually invested $100,000 in ASEA in exchange for a 1% interest in the company. 4 O’Loughlin later claimed that it was crucial to him that ASEA own the intellectual property behind its products and that Sorensen and others had assured him that it did. But years later, O’Loughlin learned that this was not the case and ASEA had actually been making royalty payments to license the intellectual property from Reoxcyn. He also learned that other ASEA founders were linked to Reoxcyn, with Sorensen serving as Reoxcyn’s CEO.

¶4 O’Loughlin sued ASEA and Reoxcyn, amending the complaint twice to add Sorensen as a defendant and to raise additional claims. 5 In his second amended complaint, O’Loughlin raised thirteen claims. 6 His first cause of action, titled “Breach of Operating Agreement—§ 48-3a-407(3)(c),” alleged that ASEA had transferred its intellectual property to Reoxcyn “outside the ordinary course of [ASEA’s] activities and affairs,” violating the Utah Code and harming ASEA’s shareholders. The other claims alleged breach of the duties of loyalty and care, fraudulent transfer, fraudulent and negligent misrepresentation, interference with contract, breach of the covenant of good faith and fair dealing, violation of the Utah Trade Secrets Act, conversion, unjust enrichment, and civil conspiracy. O’Loughlin directed some of these claims against ASEA; some against Sorensen; and some against ASEA, Sorensen, and Reoxcyn (collectively, the

4. O’Loughlin transferred the resultant stocks to three different trusts of which he is a trustee. He sued in his capacity as trustee.

5. Several of O’Loughlin’s claims against Sorensen and Reoxcyn were dismissed prior to the filing of O’Loughlin’s second amended complaint.

6. O’Loughlin raised both direct and derivative claims, though he later elected to pursue only the direct claims.

20231088-CA 3 2026 UT App 41 O’Loughlin v. ASEA Enterprises

Defendants). O’Loughlin sought damages as well as declaratory and injunctive relief. 7

Discovery

¶5 Once discovery began, O’Loughlin filed his initial disclosures per rule 26(a)(1) of the Utah Rules of Civil Procedure. The disclosures included a section titled “Computation of Damages” that stated, “A computation of damages as contemplated by Rule 26(a)(1) is not available at this time because said information is in the possession of Defendants.”

¶6 In its first set of discovery requests, ASEA asked O’Loughlin to “[i]dentify and describe in detail and with specificity the nature and dollar value of all damages . . . together with a calculation and methodology used for determining the alleged damages.” O’Loughlin did not do so and instead objected to the request, stating, “The point of this legal action is to uncover facts hidden by [the] Defendants” in order to establish his various claims and “to determine the damages” incurred.

¶7 But O’Loughlin did not make his first set of discovery requests for any such information from the Defendants until December 3, 2021—though fact discovery was set to end on February 25, 2022. 8 After receiving ASEA’s response—including its profit and loss statements—O’Loughlin served his expert

7. O’Loughlin later filed a motion to further amend the complaint, which the district court denied.

8. Due to several delays, the district court had reset discovery in June 2020. O’Loughlin had made discovery requests prior to June 2020 but apparently did not renew them. Fact discovery was set to end on February 25, 2022, but the parties apparently stipulated to an extension of that deadline until March 4, 2022, “to respond to certain outstanding written discovery requests.”

20231088-CA 4 2026 UT App 41 O’Loughlin v. ASEA Enterprises

witness disclosure. The disclosure listed an expert (Expert) who would opine that O’Loughlin’s damages were as follows:

1% of Reoxcyn Royalty Payments, 2009–2020 = $409,100

Interest on $409,100.70, at 13.87%, 2009–2021 = $436,255

Diminished Value of Plaintiff’s Shares—$2,045,504

Income made from ASEA IP and Patents by 3rd Parties—unknown

Income made from ASEA IP and Patents by Reoxcyn Entities—unknown

Value of 1% Interest in Reoxcyn and related entities—unknown

Other damages from corporate raiding—unknown

¶8 After submitting his expert disclosure, O’Loughlin was deposed by the Defendants. The only measure of damages he discussed in detail was his claim that, as a member of ASEA, he had “proportional owner[ship] in Reoxcyn” and was entitled to “one percent of the royalties less expenses” payable by Reoxcyn.

¶9 In several later supplements to his initial disclosures, O’Loughlin did not attempt to further clarify his damages claim. But on March 4, 2022, the last day of fact discovery, O’Loughlin supplemented his expert disclosure with a worksheet containing the figures on which Expert’s damages estimates were based.

¶10 Expert was also eventually deposed by the Defendants. Expert discussed four theories for calculating damages, three of

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Taylor Ex Rel. Taylor v. Ogden City School District
927 P.2d 159 (Utah Supreme Court, 1996)
Okelberry v. WEST DANIELS LAND ASSOCIATION
2005 UT App 327 (Court of Appeals of Utah, 2005)
Bodell Construction Co. v. Robbins
2009 UT 52 (Utah Supreme Court, 2009)
Build, Inc. v. Utah Dep't of Transp.
2018 UT 34 (Utah Supreme Court, 2018)
Keystone Insurance Agency v. Inside Insurance
2019 UT 20 (Utah Supreme Court, 2019)
Scott v. Wingate Wilderness Therapy
2021 UT 28 (Utah Supreme Court, 2021)
Hitorq v. TCC Veterinary Services
2021 UT 69 (Utah Supreme Court, 2021)
Vanlaningham v. Hart
2021 UT App 95 (Court of Appeals of Utah, 2021)
Sleepy Holdings LLC v. Mountain West Title
2016 UT App 62 (Court of Appeals of Utah, 2016)
True v. Utah Department of Transportation
2018 UT App 86 (Court of Appeals of Utah, 2018)
Hitorq v. TCC Veterinary Services
2020 UT App 123 (Court of Appeals of Utah, 2020)
Hooban v. Unicity International, Inc.
2012 UT 40 (Utah Supreme Court, 2012)
Ockey v. Club Jam
2014 UT App 126 (Court of Appeals of Utah, 2014)
Butler v. Mediaport Entertainment
2022 UT App 37 (Court of Appeals of Utah, 2022)
Airstar v. Keystone Aviation
2022 UT App 73 (Court of Appeals of Utah, 2022)
S6 v. Wing Enterprises
2024 UT App 105 (Court of Appeals of Utah, 2024)
Capozzoli v. Madden
2024 UT App 176 (Court of Appeals of Utah, 2024)
Meade Recovery Services v. Davidson
2025 UT App 97 (Court of Appeals of Utah, 2025)
Globe Contracting v. Hour
2025 UT App 98 (Court of Appeals of Utah, 2025)

Cite This Page — Counsel Stack

Bluebook (online)
2026 UT App 41, Counsel Stack Legal Research, https://law.counselstack.com/opinion/oloughlin-v-aesa-enterprises-utahctapp-2026.